- call +1-201-465-4211
- email sales@mrinsights.biz
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
Scope of the Report:
This report focuses on the Docetaxel in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of Docetaxel includes 20 mg/ml, 40 mg/ml and 60 mg/ml. And the proportion of 20 mg/ml in 2017 is about 86% and the proportion is stable from 2013 to 2017.
Docetaxel is widely used For Breast Cancer, Prostate Cancer, Non-small Cell Lung Cancer and Cancer. The most proportion of Docetaxel used for Breast Cancer and the proportion in 2017 is 85%.
The worldwide market for Docetaxel is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Hengrui Medicine
Sanofi
Qilu Pharma
Shenzhen Main Luck Pharma
Jiangsu Aosaikang Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
20 mg/ml
40 mg/ml
60 mg/ml
Market Segment by Applications, can be divided into
Breast Cancer
Prostate Cancer
Non-small Cell Lung Cancer
Other
There are 15 Chapters to deeply display the global Docetaxel market.
Chapter 1, to describe Docetaxel Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Docetaxel, with sales, revenue, and price of Docetaxel, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Docetaxel, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Docetaxel market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Docetaxel sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Docetaxel Introduction
1.2 Market Analysis by Type
1.2.1 20 mg/ml
1.2.2 40 mg/ml
1.2.3 60 mg/ml
1.3 Market Analysis by Applications
1.3.1 Breast Cancer
1.3.2 Prostate Cancer
1.3.3 Non-small Cell Lung Cancer
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hengrui Medicine
2.1.1 Business Overview
2.1.2 Docetaxel Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hengrui Medicine Docetaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Docetaxel Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Docetaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Qilu Pharma
2.3.1 Business Overview
2.3.2 Docetaxel Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Qilu Pharma Docetaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Shenzhen Main Luck Pharma
2.4.1 Business Overview
2.4.2 Docetaxel Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Shenzhen Main Luck Pharma Docetaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Jiangsu Aosaikang Pharma
2.5.1 Business Overview
2.5.2 Docetaxel Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Jiangsu Aosaikang Pharma Docetaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Docetaxel Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Docetaxel Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Docetaxel Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Docetaxel Manufacturer Market Share in 2017
3.3.2 Top 6 Docetaxel Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Docetaxel Market Analysis by Regions
4.1 Global Docetaxel Sales, Revenue and Market Share by Regions
4.1.1 Global Docetaxel Sales and Market Share by Regions (2013-2018)
4.1.2 Global Docetaxel Revenue and Market Share by Regions (2013-2018)
4.2 North America Docetaxel Sales and Growth Rate (2013-2018)
4.3 Europe Docetaxel Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Docetaxel Sales and Growth Rate (2013-2018)
4.5 South America Docetaxel Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Docetaxel Sales and Growth Rate (2013-2018)
5 North America Docetaxel by Countries
5.1 North America Docetaxel Sales, Revenue and Market Share by Countries
5.1.1 North America Docetaxel Sales and Market Share by Countries (2013-2018)
5.1.2 North America Docetaxel Revenue and Market Share by Countries (2013-2018)
5.2 United States Docetaxel Sales and Growth Rate (2013-2018)
5.3 Canada Docetaxel Sales and Growth Rate (2013-2018)
5.4 Mexico Docetaxel Sales and Growth Rate (2013-2018)
6 Europe Docetaxel by Countries
6.1 Europe Docetaxel Sales, Revenue and Market Share by Countries
6.1.1 Europe Docetaxel Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Docetaxel Revenue and Market Share by Countries (2013-2018)
6.2 Germany Docetaxel Sales and Growth Rate (2013-2018)
6.3 UK Docetaxel Sales and Growth Rate (2013-2018)
6.4 France Docetaxel Sales and Growth Rate (2013-2018)
6.5 Russia Docetaxel Sales and Growth Rate (2013-2018)
6.6 Italy Docetaxel Sales and Growth Rate (2013-2018)
7 Asia-Pacific Docetaxel by Countries
7.1 Asia-Pacific Docetaxel Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Docetaxel Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Docetaxel Revenue and Market Share by Countries (2013-2018)
7.2 China Docetaxel Sales and Growth Rate (2013-2018)
7.3 Japan Docetaxel Sales and Growth Rate (2013-2018)
7.4 Korea Docetaxel Sales and Growth Rate (2013-2018)
7.5 India Docetaxel Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Docetaxel Sales and Growth Rate (2013-2018)
8 South America Docetaxel by Countries
8.1 South America Docetaxel Sales, Revenue and Market Share by Countries
8.1.1 South America Docetaxel Sales and Market Share by Countries (2013-2018)
8.1.2 South America Docetaxel Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Docetaxel Sales and Growth Rate (2013-2018)
8.3 Argentina Docetaxel Sales and Growth Rate (2013-2018)
8.4 Colombia Docetaxel Sales and Growth Rate (2013-2018)
9 Middle East and Africa Docetaxel by Countries
9.1 Middle East and Africa Docetaxel Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Docetaxel Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Docetaxel Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Docetaxel Sales and Growth Rate (2013-2018)
9.3 UAE Docetaxel Sales and Growth Rate (2013-2018)
9.4 Egypt Docetaxel Sales and Growth Rate (2013-2018)
9.5 Nigeria Docetaxel Sales and Growth Rate (2013-2018)
9.6 South Africa Docetaxel Sales and Growth Rate (2013-2018)
10 Global Docetaxel Market Segment by Type
10.1 Global Docetaxel Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Docetaxel Sales and Market Share by Type (2013-2018)
10.1.2 Global Docetaxel Revenue and Market Share by Type (2013-2018)
10.2 20 mg/ml Sales Growth and Price
10.2.1 Global 20 mg/ml Sales Growth (2013-2018)
10.2.2 Global 20 mg/ml Price (2013-2018)
10.3 40 mg/ml Sales Growth and Price
10.3.1 Global 40 mg/ml Sales Growth (2013-2018)
10.3.2 Global 40 mg/ml Price (2013-2018)
10.4 60 mg/ml Sales Growth and Price
10.4.1 Global 60 mg/ml Sales Growth (2013-2018)
10.4.2 Global 60 mg/ml Price (2013-2018)
11 Global Docetaxel Market Segment by Application
11.1 Global Docetaxel Sales Market Share by Application (2013-2018)
11.2 Breast Cancer Sales Growth (2013-2018)
11.3 Prostate Cancer Sales Growth (2013-2018)
11.4 Non-small Cell Lung Cancer Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Docetaxel Market Forecast (2018-2023)
12.1 Global Docetaxel Sales, Revenue and Growth Rate (2018-2023)
12.2 Docetaxel Market Forecast by Regions (2018-2023)
12.2.1 North America Docetaxel Market Forecast (2018-2023)
12.2.2 Europe Docetaxel Market Forecast (2018-2023)
12.2.3 Asia-Pacific Docetaxel Market Forecast (2018-2023)
12.2.4 South America Docetaxel Market Forecast (2018-2023)
12.2.5 Middle East and Africa Docetaxel Market Forecast (2018-2023)
12.3 Docetaxel Market Forecast by Type (2018-2023)
12.3.1 Global Docetaxel Sales Forecast by Type (2018-2023)
12.3.2 Global Docetaxel Market Share Forecast by Type (2018-2023)
12.4 Docetaxel Market Forecast by Application (2018-2023)
12.4.1 Global Docetaxel Sales Forecast by Application (2018-2023)
12.4.2 Global Docetaxel Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Docetaxel Picture
Table Product Specifications of Docetaxel
Figure Global Sales Market Share of Docetaxel by Types in 2017
Table Docetaxel Types for Maj
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
